甲胺调节的阿迪波基因生物化学标记在2型糖尿病患者中的生物化学标记
H Toaama1, E Sarhat1, H Mohammed1
1College of Medicine, University of Tikrit, Iraq.
Georgian medical news
|August 1, 2024
概括
对2型糖尿病 (T2DM) 的甲福明治疗有效地降低了素,维斯法丁和RBP4.4的血清水平升高. 这些生物标志物可能有助于区分T2DM患者,需要进一步的临床研究.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 2型糖尿病 (T2DM) 是一种普遍的代谢障碍,与长期并发症有关.
- 甲福明是治疗T2DM的主要治疗剂.
- 虹膜素,维斯法丁和RBP4是涉及T2DM病理生理学的潜在生物标志物.
研究的目的:
- 在T2DM患者中评估血清里素,维斯法丁和RBP4水平.
- 研究甲福明治疗对T2DM中这些生物标志物水平的影响.
主要方法:
- 研究了70名T2DM患者 (48-82岁) 的队列和对照组.
- 使用ELISA套件分析血清样本,以测量虹膜素,视法丁和RBP4度.
- 在T2DM患者和对照者之间,在甲福明治疗3个月之前和之后,生物标志物水平进行了比较.
主要成果:
- 与对照组相比,T2DM患者的血清中虹素,视沙丁和RBP4水平显著更高.
- 三个月的甲福明治疗导致T2DM患者的虹素,视法丁和RBP4水平显著降低.
- 接收器操作员特征 (ROC) 曲线分析表明,视法丁和虹膜素水平是区分T2DM的有效生物标志物.
结论:
- 在T2DM患者中,为期3个月的甲福明治疗有效降低了虹膜素,视法丁和RBP4水平.
- 这些甲胺诱导的生物标志物变化的临床影响需要进一步研究.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
186
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
186
Carbohydrate Metabolism
10.9K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.9K
Dipeptidyl Peptidase 4 Inhibitors
180
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
180
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes: Symptoms, Diagnosis, and Complications
521
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
521
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
168
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
168


